Yongfeng Shuai, Jiacong Liu, Yuhong Yang, Xuhua Huang, Jiayue Ye, Linhai Zhu et al. Neoadjuvant immunochemotherapy versus chemotherapy for elderly patients with IB–IIIB non-small-cell lung cancer in real-world practice. // BMC Cancer. – 2025. – DOI: 10.1186/s12885-025-14545-7. – URL: https://doi.org/10.1186/s12885-025-14545-7
Yongfeng Shuai, Jiacong Liu, Yuhong Yang, Xuhua Huang, Jiayue Ye, Linhai Zhu, & Jian Hu (2025). Neoadjuvant immunochemotherapy versus chemotherapy for elderly patients with IB–IIIB non-small-cell lung cancer in real-world practice. BMC Cancer. https://doi.org/10.1186/s12885-025-14545-7
Yongfeng Shuai, et al. “Neoadjuvant immunochemotherapy versus chemotherapy for elderly patients with IB–IIIB non-small-cell lung cancer in real-world practice.” BMC Cancer, 2025. doi:10.1186/s12885-025-14545-7.
@article{Shuai2025,
title = {Neoadjuvant immunochemotherapy versus chemotherapy for elderly patients with IB–IIIB non-small-cell lung cancer in real-world practice},
author = {Shuai, Yongfeng and Liu, Jiacong and Yang, Yuhong and Huang, Xuhua and Ye, Jiayue and Zhu, Linhai and Hu, Jian},
journal = {BMC Cancer},
year = {2025},
doi = {10.1186/s12885-025-14545-7},
url = {https://doi.org/10.1186/s12885-025-14545-7}
}